Unlabeled Use for Anti-Cancer Drugs: Medical Literature Used to Determine Medically Accepted Indications for Drugs and Biologicals Used in Anti-Cancer Treatment
CMS is adding to the current list at chapter 15, section 50.4.5 of the
Medicare Benefit Policy Manual the following journals:
Annals of Oncology
Biology of Blood and Marrow Transplantation
Bone Marrow Transplantation
Gynecologic Oncology
Clinical Cancer Research
International Journal of Radiation, Oncology, Biology, and Physics
Journal of NCCN
Radiation Oncology
Annals of Surgical Oncology
Journal of Urology
Lancet Oncology
CMS is not deleting any of the current journals at this time.
Issued by: Centers for Medicare & Medicaid Services (CMS)
Issue Date: September 21, 2007
DISCLAIMER: The contents of this database lack the force and effect of law, except as authorized by law (including Medicare Advantage Rate Announcements and Advance Notices) or as specifically incorporated into a contract. The Department may not cite, use, or rely on any guidance that is not posted on the guidance repository, except to establish historical facts.